TY - JOUR T1 - Drivers of Frailty from Adulthood into Old Age: Results from a 27-year Longitudinal Population-Based Study in Sweden JF - medRxiv DO - 10.1101/19012476 SP - 19012476 AU - Emma Raymond AU - Chandra A. Reynolds AU - Anna K. Dahl Aslan AU - Deborah Finkel AU - Malin Ericsson AU - Sara Hägg AU - Nancy L. Pedersen AU - Juulia Jylhävä Y1 - 2019/01/01 UR - http://medrxiv.org/content/early/2019/11/25/19012476.abstract N2 - Background Frailty is a strong predictor of adverse aging outcomes. However, the longitudinal drivers of frailty are not well understood. This study aimed at investigating the longitudinal trajectories of a frailty index (FI) from adulthood to late life and identifying the predictors of the level and rate of change in FI.Methods An age-based latent growth curve analysis was performed in the Swedish Adoption/Twin Study of Aging (N=1,842; aged 29-102 years) using data from up to 15 measurement waves across 27 years. A 42-item FI was used to measure frailty at each wave.Results A bilinear, two-slope model with a turning point at age 65 best described the age-related change in FI, showing that the rate of increase in frailty was more than twice as fast after age 65. Underweight, obesity, female sex, overweight, being separated from one’s co-twin during childhood, smoking, poor social support and low physical activity were associated with a higher level of FI at age 65, with underweight having the largest effect size. When tested as time-varying predictors, underweight and higher social support were associated with a steeper increase in FI before age 65, whereas overweight and obesity were associated with less steep increase in FI after age 65.Conclusions Predictors for the level and rate of change in frailty are largely actionable and could provide targets for intervention. Underweight increased the risk of higher FI trajectory until age 65, whereas being overweight or obese were associated with slower progression of frailty towards the oldest ages.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe SATSA study was supported by National Institute of Health (grant numbers R01 AG04563, AG10175, AG028555); the MacArthur Foundation Research Network on Successful Aging; the Swedish Council for Working Life and Social Research (FAS/FORTE) (grant numbers 97:0147:1B, 2009-0795) and the Swedish Research Council (825-2007-7460, 825-2009-6141). This study is supported by the Swedish Research Council (grant numbers 521-2013-8689, 2015-03255, 2018-02077; 2016-03081); JPND/Swedish Research Council (2015-06796); FORTE (2013-2292); the Loo & Hans Osterman Foundation to SH and JJ; the Foundation for Geriatric Diseases to SH; the Magnus Bergwall Foundation to SH; the Strategic Research Program in Epidemiology at Karolinska Institutet to SH and JJ and the King Gustaf V’s and Queen Victoria’s Freemason Foundation to SH.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesSATSA questionnaire and in-person testing data up to the seventh testing wave are available at: https://www.icpsr.umich.edu/icpsrweb/NACDA/studies/3843 ER -